TAMs may transfer miR-223 to HCC cells in a contact-dependent manner involving gap junctions, thereby inhibiting HCC cell proliferation by targeting the STMN1 and IGF-1R genes84. The gene discussed is STMN1; the disease is hepatocellular carcinoma.